CAPOLLA, SARA
 Distribuzione geografica
Continente #
NA - Nord America 16.553
EU - Europa 14.071
AS - Asia 12.158
SA - Sud America 4.729
AF - Africa 544
OC - Oceania 395
Continente sconosciuto - Info sul continente non disponibili 14
Totale 48.464
Nazione #
US - Stati Uniti d'America 14.597
CN - Cina 4.702
IT - Italia 4.483
BR - Brasile 2.730
ES - Italia 1.566
DE - Germania 1.310
MX - Messico 1.272
JP - Giappone 1.151
IN - India 1.038
GB - Regno Unito 1.015
FR - Francia 900
TR - Turchia 866
PL - Polonia 795
ID - Indonesia 753
SG - Singapore 536
NL - Olanda 504
CO - Colombia 477
CA - Canada 471
PT - Portogallo 464
TW - Taiwan 447
HK - Hong Kong 435
AR - Argentina 433
VN - Vietnam 405
PE - Perù 382
GR - Grecia 344
CL - Cile 339
AU - Australia 331
KR - Corea 321
SE - Svezia 280
RU - Federazione Russa 272
AT - Austria 261
TH - Thailandia 253
CH - Svizzera 241
BE - Belgio 212
EC - Ecuador 209
RO - Romania 191
SA - Arabia Saudita 180
FI - Finlandia 177
DK - Danimarca 163
PK - Pakistan 148
EG - Egitto 143
IR - Iran 138
IE - Irlanda 109
IL - Israele 109
CZ - Repubblica Ceca 104
MY - Malesia 94
HU - Ungheria 88
MA - Marocco 79
HR - Croazia 74
PH - Filippine 74
ZA - Sudafrica 74
UA - Ucraina 70
SI - Slovenia 68
RS - Serbia 65
NZ - Nuova Zelanda 61
BD - Bangladesh 56
VE - Venezuela 55
TN - Tunisia 54
LT - Lituania 52
IQ - Iraq 49
NO - Norvegia 49
LB - Libano 48
LV - Lettonia 47
PA - Panama 45
BG - Bulgaria 43
BO - Bolivia 40
KZ - Kazakistan 37
AE - Emirati Arabi Uniti 35
CR - Costa Rica 35
JO - Giordania 35
SK - Slovacchia (Repubblica Slovacca) 35
UY - Uruguay 35
GT - Guatemala 34
NG - Nigeria 31
DZ - Algeria 28
QA - Qatar 26
LK - Sri Lanka 23
HN - Honduras 22
NP - Nepal 22
PS - Palestinian Territory 21
PY - Paraguay 21
SY - Repubblica araba siriana 20
CY - Cipro 19
BY - Bielorussia 18
DO - Repubblica Dominicana 17
UZ - Uzbekistan 17
ET - Etiopia 16
GE - Georgia 15
NI - Nicaragua 14
OM - Oman 14
EE - Estonia 13
KW - Kuwait 12
MO - Macao, regione amministrativa speciale della Cina 12
BA - Bosnia-Erzegovina 11
KE - Kenya 11
PR - Porto Rico 11
RE - Reunion 11
AL - Albania 10
CD - Congo 10
CU - Cuba 10
Totale 48.243
Città #
Ashburn 8.402
Germantown 1.013
Milan 560
Rome 541
São Paulo 486
Warsaw 423
Beijing 414
Madrid 408
Trieste 401
Shanghai 351
Singapore 346
Guangzhou 328
Istanbul 300
Tokyo 297
Barcelona 248
Lima 248
Rio de Janeiro 240
Paris 235
Dallas 226
Munich 219
Bogotá 208
Los Angeles 202
Hangzhou 199
New York 187
Athens 182
Buenos Aires 181
Taipei 179
Santiago 177
Frankfurt am Main 175
Jakarta 168
Lisbon 167
San Jose 158
Vienna 158
Chicago 155
Ho Chi Minh City 148
Hong Kong 148
Naples 148
Ankara 147
Chengdu 142
Bangkok 138
Bologna 138
Turin 138
Houston 137
Bengaluru 132
Florence 127
Amsterdam 126
Fairfield 117
Hanoi 117
Chandler 113
Curitiba 110
Helsinki 108
Brasília 107
London 104
Berlin 103
Medellín 103
Hyderabad 100
Melbourne 100
Nanjing 97
Valencia 97
Chennai 96
Mumbai 96
Seattle 95
Woodbridge 95
Zurich 95
Las Vegas 94
Ann Arbor 93
Wuhan 91
Dublin 90
Sydney 90
Copenhagen 88
Quito 88
Guadalajara 87
Thessaloniki 87
Porto 86
Porto Alegre 86
Benito Juarez 85
Council Bluffs 84
Moscow 83
Goiânia 81
Belo Horizonte 80
Cambridge 80
Washington 79
Toronto 77
Brussels 76
Montreal 76
The Dalles 75
Shenzhen 74
Bari 73
Boston 73
Seoul 73
New Delhi 71
Genoa 69
Riyadh 69
Verona 69
Hefei 68
Krakow 66
Mexico City 65
Recife 65
Shenyang 65
Budapest 64
Totale 24.524
Nome #
Bispecific antibodies targeting tumor-associated antigens and neutralizing complement regulators increase the efficacy of antibody-based immunotherapy in mice. 44.770
Targeted tumor imaging of anti-CD20-polymeric nanoparticles developed for the diagnosis of B-cell malignancies 446
Complement as a biological tool to control tumor growth 316
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 304
A new approach for the treatment of CLL using chlorambucil/hydroxychloroquine-loaded anti-CD20 nanoparticles 282
Targeted nanoparticles and complement activation 282
Diagnostic and prognostic role of eEF1A in chronic lymphocytic leukaemia 248
Effects of eEF1A1 targeting by aptamer/siRNA in chronic lymphocytic leukaemia cells 216
The Dual Role of the Liver in Nanomedicine as an Actor in the Elimination of Nanostructures or a Therapeutic Target 199
Biological Features of Nanoparticles: Protein Corona Formation and Interaction with the Immune System 175
Nanoparticles-based oligonucleotides delivery in cancer: Role of zebrafish as animal model 170
A novel complement-fixing IgM antibody targeting GPC1 as a useful immunotherapeutic strategy for the treatment of pancreatic ductal adenocarcinoma 167
Constitutive psgl-1 correlates with cd30 and tcr pathways and represents a potential target for immunotherapy in anaplastic large t-cell lymphoma 159
The anti-glypican 1 AT101 antibody as targeting agent to effectively deliver chitosan nanobubbles to glioblastoma cells. 147
Zebrafish: A Useful Animal Model for the Characterization of Drug-Loaded Polymeric NPs 145
Idarubicin-loaded chitosan nanobubbles to improve survival and decrease drug side effects in hepatocellular carcinoma 140
Potential therapeutic role of antagomiR17 for the treatment of chronic lymphocytic leukemia. 138
Plasminogen activator-coated nanobubbles targeting cell-bound β2-glycoprotein I as a novel thrombus-specific thrombolytic strategy 134
null 117
Surface antibody changes protein corona both in human and mouse serum but not final opsonization and elimination of targeted polymeric nanoparticles 9
Mechanistic Divergence and Differential Antibacterial Potency of the Proline-Rich Antimicrobial Peptide B7-005 Across ESKAPE + E Pathogens 8
Targeted chitosan nanobubbles as a strategy to down-regulate microRNA-17 into B-cell lymphoma models 7
Totale 48.579
Categoria #
all - tutte 56.012
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.012


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202116 0 0 0 0 0 0 0 0 0 0 0 16
2021/2022210 20 7 15 8 6 14 11 18 26 15 14 56
2022/2023330 20 49 25 56 18 47 19 36 39 6 11 4
2023/2024289 15 11 23 11 35 48 56 32 4 21 19 14
2024/202519.124 6 22 23 59 52 82 83 78 114 82 5.757 12.766
2025/202627.512 5.301 4.660 5.307 4.870 4.696 1.873 214 40 227 177 100 47
Totale 48.579